Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.035 CAD | 0.00% | 0.00% | 0.00% |
Apr. 26 | Appili Therapeutics Inc. announced that it has received CAD 0.3 million in funding | CI |
Apr. 02 | Appili Therapeutics To be Acquired by Aditxt, Inc. | MT |
Business Summary
Number of employees: 9
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -75.97% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -75.97% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Don Cilla
CEO | Chief Executive Officer | 63 | 20-10-31 |
Armand Balboni
CHM | Chairman | 57 | 18-09-30 |
Kenneth Howling
DFI | Director of Finance/CFO | 66 | 21-11-15 |
Carl Gelhaus
CTO | Chief Tech/Sci/R&D Officer | - | - |
Leona Saunders
LAW | General Counsel | - | - |
Myriam Triest
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | 19-09-30 | |
Gary Nabors
PRN | Corporate Officer/Principal | - | 23-04-02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 20-01-26 | |
Prakash Gowd
BRD | Director/Board Member | 60 | Nov. 12 |
Director/Board Member | 70 | 21-02-01 | |
Brian Bloom
BRD | Director/Board Member | 48 | 15-05-06 |
Director/Board Member | 56 | 18-09-30 | |
Armand Balboni
CHM | Chairman | 57 | 18-09-30 |
Don Cilla
CEO | Chief Executive Officer | 63 | 20-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 121,266,120 | 121,191,120 ( 99.94 %) | 0 | 99.94 % |
Company contact information
Appili Therapeutics, Inc.
1344 Summer Street Suite 21
B3H 0A8, Halifax
+
http://www.appilitherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 3.11M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- APLI Stock
- Company Appili Therapeutics Inc.